Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda.
Christina L FaustMarco CrottiArinaitwe MosesDavid OguttuAidah WambokoMoses AdrikoElizabeth K AdekanleNarcis KabatereineEdridah M TukahebwaAlice J NortonCharlotte M GowerJoanne P WebsterPoppy H L LambertonPublished in: Parasites & vectors (2019)
Our findings suggest that praziquantel treatments have short-term impacts on these parasite populations but impacts were transient and no long-term reduction in genetic diversity was observed. High gene flow reduces the likelihood of local adaptation, so even though parasites surviving treatment were observed, these were likely to be diluted at the beginning of the Ugandan National Control Programme. Together, these results suggest that MDA in isolation may be insufficient to reduce schistosome populations in regions with high genetic diversity and gene flow.